Botfet / Company detail

ILMN

watchlist

Illumina, Inc.

biotech

Moat scoreNot available: not scored quality failout of 100

On watchlist · qualityThis name is being monitored for a specific quality or thesis issue.

The numbers

Financial metrics

Quality gate and thesis context

Roic12.0%

Gross Margin66.7%

Revenue Cagr-1.1%

Fcf Conversion109.5%

Fcf Yield2.3%

Interest Coverage14.4x

Market Cap B$40.9B

Pe49.8

Quality PassFail

Founder LedNo

Thesis AlignedYes

Moat QuantNot available: not scored quality fail

Why it may endure

Quant: · Curator:

Market Share StabilityNot available: not scored quality fail

Network EffectsNot available: not scored quality fail

Pricing PowerNot available: not scored quality fail

Regulatory MoatNot available: not scored quality fail

Switching CostsNot available: not scored quality fail

ConvictionNot available: not scored quality fail

LeadershipNot available: not scored quality fail

VisionNot available: not scored quality fail